The neuromuscular and cardiovascular activities of pancuronium were compared with those of its 16(3 monoquaternary congener, Org NC 45, in the anaesthetized rat, cat and rhesus monkey. In the rat Org NC 45 was 3.4 times less potent as a neuromuscular blocking agent than was pancuronium. In the cat, both drugs were found to be approximately equally eliminated by the liver, whereas renal elimination was observed only with pancuronium. In the rhesus monkey, Org NC 45 was about 1.5 times less potent than pancuronium as a neuromuscular blocking agent. At doses approximately eight times that producing 80%.twitch block, the neuromuscular block produced by Org NC 45 was significantly shorter in duration and recovery than that produced by pancuronium. In addition, these high doses of Org NC 45 did not produce the tachycardia which is seen with pancuronium. Org NC 45 showed less tendency than pancuronium to produce cumulative effects on repeated administration in the monkey. Both Org NC 45 and pancuronium were antagonized by anti-cholinesterases and aminopyridines. It is suggested that the lack of tachycardia with Org NC 45 may be related to the low cardio-selective anti-muscarinic potency of Org NC 45 previously reported in the cat and, together with its low renal elimination and lack of cumulative effects, Org NC 45 may be a clinically useful non-depolarizing muscle relaxant free of cardiovascular side-effects.
only at doses many times greater than those producing submaximal neuromuscular block.
We compared Org NC 45 and pancuronium in the rat, cat and rhesus monkey. Particular attention has been paid to the effect of Org NC 45 on the heart rate in the rhesus monkey and to the elimination of Org NC 45 in the cat, since both these factors are of clinic?! importance.
METHODS
Anaesthetized rat sciatic nerve-tibialis anterior muscle preparation Male rats (300-600 g) were anaesthetized with pentobarbitone sodium 60 mg kg" 1 i.p. and the lungs were artificially ventilated with air at a rate of 100 b.p.m. and a tidal volume of 7 ml kg-1 . Body temperature was maintained at 37-38 °C and drugs were administered through a polythene cannula placed in a jugular vein. Arterial pressure was recorded via a polythene cannula placed in a carotid artery. The sciatic nerve was stimulated by rectangular pulses of 0.2 ms duration, a frequency of 0.1 Hz and at sufficient stimulus strength to elicit maximal twitch responses of the tibialis anterior muscle.
Anaesthetized cat sciatic nerve-tibialis anterior muscle preparation Cats of either sex (2.4-^.5 kg) were anaesthetized with pentobarbitone sodium 40 mg kg" 1 i.p. and were artificially ventilated with air at a rate of 26 b.p.m. and a tidal volume of 18 ml kg" 1 . Body temperature was maintained at 36-38 °C and drugs were administered through a polythene rnnrmia placed in a jugular vein. Arterial pressure was recorded via a polythene cannula placed in a carotid artery. The sciatic nerve in the popliteal space was stimulated with rectangular pulses of the same parameters as described above to elicit maximal twitch responses of the tibialis anterior muscle.
To exclude the liver from the general circulation, the method described by Agoston, Houwertjes and Salt (1980) was used.
Initially, a control dose of antagonist sufficient to produce an 80-90% reduction of twitch tension was administered via the jugular vein. The same dose was then used throughout the experiment. The second administration was made whilst the liver was bypassed for 10 min. The third administration was made via the portal vein. The fourth administration was a control given via the jugular vein, and the final administration was made whilst the liver was permanently by-passed. The sequence of the second and third administrations was reversed in half of the experiments.
To exclude the kidneys from the general circulation a clip was applied to the renal artery and vein of both kidneys.
Initially, a control dose of antagonist sufficient to produce an 80-90% reduction of twitch tension was administered via the jugular vein. The same dose was then used throughout the experiment. The second administration was made whilst the kidneys were temporarily excluded for 10 min. The third administration was a control, and the fourth and final administration was made whilst the kidneys were permanently excluded.
The time between administrations was 2 h for pancuronium and 1 h for Org NC 45; initial studies indicated that these two time intervals resulted in the minimum cumulative effect.
Anaesthetized rhesus monkey ulnar nerve-adductor pollicis muscle preparation Rhesus monkeys of either sex (4.7-11.5 kg) were anaesthetized with ketamine hydrochloride 10 mg kg~x i.m. and pentobarbitone sodium 30 mg total dose and were artificially ventilated with 67% nitrous oxide in oxygen at a rate of 20 b.p.m. and tidal volume of 12 ml kg" 1 . Drugs were administered i.v. through an indwelling polyethylene cannula placed in the saphenous vein. E.c.g. was recorded (heart rate).
The ulnar nerve was stimulated via two polar subcutaneous needle electrodes with rectangular pulses of the same parameters as those described above. The twitch responses of the adductor pollicis muscle were recorded via a Statham UC3 transducer attached by a wire to a small U-clamp which could be fixed firmly to the basal phalanx of the thumb.
Drug and solutions
Drugs used were: 3,4-diaminopyridine, atropine sulphate, heparin, ketamine hydrochloride, neostigmine methylsulphate, pancuronium bromide, Org NC 45 bromide and pentobarbitone sodium. Org NC 45 was dissolved at a concentration of 1 mg ml-1 in 2.1 mg ml" 1 of citric acid to prevent alkaline hydrolysis; a fresh solution was used for each experiment. Other drugs were dissolved in 0.9% saline. Doses are expressed as weight in terms of the salt when appropriate.
Statistics
Neuromuscular blockade during a drug effect was measured as the percentage depression of twitch tension relative to the height of the control twitch responses. Onset of neuromuscular blockade was measured as the time from injection to maximum depression of twitch tension, duration time as the time from injection to either 50% or 90% recovery of twitch height and recovery time as the time from 25% to 75 % recovery of twitch height. Results are presented as the mean±SEM of at least four observations except when indicated. The dose which produced a 50% inhibition of twitch tension was determined by regression analysis of the log-dose-effect curve. Comparisons of paired data were made with Wilcoxon's test and comparisons of unpaired data with the Mann-Whitney [/-test. Probability values of less than 0.05 were regarded as significant.
RESULTS

Neuromuscular blockade
In the rat and rhesus monkey Org NC 45 was 3.4 and 1.5 times less potent respectively than pancuronium as a neuromuscular blocking agent (jtable I), but at submaximal blocking doses the time courses of the blocks produced by the two compounds were not significantly different ( fig. 2 , table II). At doses which produced submaximal neuromuscular block in the anaesthetized rhesus monkey there was no evidence of any change in heart rate with either pancuronium or Org NC 45 ( fig. 3 ). Neuromuscular block produced by pancuronium and Org NC 45 was reversed in significantly faster time than control recovery by neostdgmine 35 |zg kg" 1 and 3,4-diamuiopyridine 1 mg kg" 1 when injected at maximal block. At the doses used, 3 3 4-diaminopyridine caused marked bradycardia which was antagonized by a total dose of atropine 0.5 mg.
TABLE I. Doses of pancuronium and Org NC 45 which produced a 50% reduction of twitch tension in the anaesthetized rat and rhesus monkey
Cumulation studies
The cumulative effects of pancuronium and Org NC 45 were tested in the anaesthetized rhesus monkey by recording the depth and duration of neuromuscular block produced by six administrations of one of three different doses of either drug. Each . 4 ). However, pancuronium exhibited a dose-dependent increase in duration of action up to the third administration, whereas Org NC 45 exhibited increase in duration only between the first and second administration ( fig. 5 ). This suggests a slight difference between the pharmacokinetics of Org NC 45 and pancuronium in the rhesus monkey. Bolus administrations of the same multiple of equi-active neuromuscular blocking doses of pancuronium 55 |ig kg" 1 resulted in a 6 ±2% increase in heart rate, but Org NC45 81 jig kg" 1 was without effect. At these high doses, Org NC45 was significantly more rapid in onset, shorter in duration and faster in recovery than pancuronium (table II) .
Effect of exclusion of the liver
Temporary (10-min) exclusion of the liver in the cat resulted in a significant increase in the depth and duration of the neuromuscular block produced by both pancuronium and Org NC45 compared with the first control doses of the drugs. Permanent exclusion of the liver also produced a significant increase in the depth and duration of the block produced by both drugs. Intra-portal vein administra- tion of Org NC 45 produced a neuromuscular block which was slightly smaller than control, but this did not occur with pancuronium (table III) . 
Effect of exclusion of the kidneys
Temporary (10-min) exclusion of the kidneys did not have a significant effect on either the depth or duration of the neuromuscular block produced by either pancuronium or Org NC 45. Permanent kidney exclusion only significantly increased the duration (to 50% recovery) and decreased the onset time of the neuromuscular block produced by pancuronium, whereas the neuromuscular block produced by Org NC 45 was unaffected (table IV) .
TABLE IV. Neuromuscular blockade of the sciatic nervetibialis anterior muscle preparation of the anaesthetized cat produced by pancuronium 22 \tg kg' 1 and Org NC 45 25-40 [i£ kg' 1 with both kidneys temporarily and permanently excluded from the general circulation, (n = 5; 'significantly different from control)
Drug and procedure 
DISCUSSION
In all three species tested, Org NC 45 was slightly less potent than pancuronium as a neuromuscular blocking agent. At submaximal blocking doses both compounds had similar time-courses of action. The potencies of Org NC 45 and pancuronium in the cat in the present study are slightly greater than previously reported (Durant et al., 1979) ; this is most probably because of the different anaesthetics used. With large doses in the monkey the time-course of the neuromuscular block produced by Org NC 45 was shorter than that of pancuronium and the increase in heart rate associated with pancuronium was not seen. Org NC 45 has been demonstrated to have only a very weak blocking action at the cardiac vagus neuroeffector junction (Durant et al., 1979; Marshall and Ojewole, 1979) and no evidence has been found that Org NC 45 enhances noradrenergic transmission (Marshall and Ojewole, 1979) . It is likely that this lack of autonomic effect at doses many times those blocking neuromuscular transmission explains the lack of cardiovascular side-effects reported by Booij and others (1980) , and the absence of tachycardia in the present study.
The neuromuscular block produced by Org NC 45 was antagonized by antichounesterases as easily as was the block produced by pancuronium, an essential requirement of any non-depolarizing muscle relaxant of potential clinical use. The neuromuscular blocks produced by both pancuronium and Org NC 45 were also antagonized by 3,4-diaminopyridine, a compound that is known to increase the] evoked release of acetylcholine (Durant and Marshall, 1978) . Based on neuromuscular block in the rhesus monkey, pancuronium and Org NC 45 exhibited similar cumulation characteristics in that both agents produced a greater depth of blockade with the second administration than with the first. This suggests, as previously demonstrated by Paton and Waud (1967) and Waud and Waud (1972) , that considerable occupation of the receptors occurs when twitch responses have returned to control height after neuromuscular block. However, pancuronium produced a more pronounced increased duration of blockade with successive doses than did Org NC 45. This suggests that the pharmacokinetics of Org NC 45 are different from those of pancuronium in the rhesus monkey. The lower cumulative effects of Org NC 45 may be of some potential clinical benefit, as prediction of additional dosage should be straightforward.
Pancuronium is eliminated mainly by the kidneys in man Tanaka, Hioki and Shindo, 1974; Buzello, 1975) and has been shown to exhibit a prolonged action in patients with impaired renal function (Popescu, 1972; Miller, Stevens and Way, 1973; McLeod, Watson and Rawlins, 1976; Hull et al., 1978) . Similarly, binary obstruction can double the plasma half-life of pancuronium in man (Somogyi, Shanks and Triggs, 1977) . The neuromuscular block produced by pancuronium administered via the intraportal vein was not significantly different from control in the present study, confirming that the liver uptake of pancuronium is small in the cat (Agoston et al., 1977) . The biliary excretion of pancuronium, reported by Agoston and others (1977) and Miller and others (1978) , was confirmed in the present study by the marked increase of the duration of the neuromuscular block when the liver was excluded.
The importance of the renal route of elimination of pancuronium in the cat is illustrated by the increase in the duration of neuromuscular blockade which accompanies renal occlusion of the circulation to the kidneys. However, neuromuscular blockade induced by Org NC 45 was not significantly altered by occlusion of the circulation to the kidneys. This observation may be explained in two different ways. First, the renal elimination of Org NC 45 is small; second, Org NC 45 is subject to rapid breakdown into non-active metabolites. In either case renal excretion of the intact molecule will be small.
The actions of Org NC 45 described, if observed in man, would make the drug a significant advance in the search for a more selective, shorter-acting muscle relaxant. Se compararon las actividades neuromusculares y cardiovasculares del pancuronium con las de su congenere monocuaternario 16(3, el Org NC 45, en la rata, gato y en mono rhesus anestesiado. El Org NC 45 fue 3,4 veces menos potente en la rata, cual un agente de bloqueo neuromuscular, que el pancuronium. Se encontro que, en el caso del gato, el higado elimin6 ambas drogas por igual, aproximadamente, mientras que solo se observ6 eliminaci6n renal cuando se uso pancuronium. En el caso del mono rhesus, el Org NC 45 fue 1,5 veces menos potente, aproximadamente, que el pancuronium, a guisa de agente de bloqueo neuromuscular. Para dosis 8 veces superiores, aproximadamente, que las que producen un bloqueo de sustenci6n del 80%, el bloqueo neuromuscular producido por el Org NC 45 fue significativamente mas corto en lo que respecta a su acci6n y recuperaci6n, que el producido por el pancuronium. Ademas, estas altas dosis de Org NC 45 no produjeron la taquicardia caracteristica del pancuronium. El Org NC 45 mostr6 menor tendencia que el pancuronium, a producir efectos acumulativos bajo administraciones sucesivas en el mono. Tanto el Org NC 45 como el pancuronium fueron contrarrestados mediante anticolinesterases y aminopiridinas. Se ha sugerido que la ausencia de taquicardia asociada con el Org NC 45 puede estar relacionada con la baja potencia cardioselectiva y antimuscarinica del Org NC 45, de la que se infonn6 anteriormente para el gato y, junto con su baja eliminaci6n renal y la ausencia de efectos acumulativos, el Org NC 45 puede que sea un relajante muscular no despolarizante de utilidad clinica que no presenta efectos secundarios cardiovasculares.
